Comprehensive Ventricular Assist Devices Market Reach USD 2.5 billion by 2015; Key players VADs market are, Abiomed, Inc., Boston Scientific Corporation, Berlin Heart GmbH, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, ReliantHeart Inc, HeartWare In

The Latest report global ventricular assist devices (VADs) market is projected to be around $2.5 billion by 2025 and it is expected to exhibit a positive growth over the forecast period. Also, rise in aging population and technological advancements in VADsare largely contributing to the positive market growth. As per a report of the Center for Diseases Control and Prevention, about 5.7 million American adults were affected by heart failure in 2016. VADs are being widely used as destination therapies for patients with advanced heart failure. Heart failure prevalence rises with age following an exponential pattern. Some potential risks associated with VENTRICULAR ASSIST DEVICESs are blood clots, excessive bleeding during and after procedure and device malfunctions.

Access Sample copy of this report: https://www.crystalmarketresearch.com/report-sample/HC0624 .

Competitive Insights: The global VENTRICULAR ASSIST DEVICESs market is a consolidated market with few large players holding the majority share of the market. The strategy adopted by these players is, acquiring small vendors and growing their product portfolio and market coverage to gain competitive advantage. The leading players in Ventricular Assist Devices market are, Abiomed, Inc., Boston Scientific Corporation, Berlin Heart GmbH, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, ReliantHeart Inc., HeartWare International, Inc., Jarvik Heart, Inc., and St. Jude Medical, Inc.

Ventricular Assist Devices Industry Outlook and Trend Analysis: In 2016, left ventricular assist devices (LVADs) segment held the maximum share of the global market. This market dominance can be attributed to rising number of cases with left ventricular damage. LVENTRICULAR ASSIST DEVICESs have varied applications in medical conditions such as heart stroke, heart failure and cardiomyopathy. They help in maintaining the required amount of blood flow throughout the body. Right ventricularassist devices (RVENTRICULAR ASSIST DEVICESs) are generally implanted in the patient’s heart after an LVENTRICULAR ASSIST DEVICES surgery or other surgery to support the right ventricle.

Key Drivers and Growth Factors:
Technological advancements in manufacturing and product design will drive the VENTRICULAR ASSIST DEVICESs market over the forecast period. Increasing prevalence of cardiovascular diseases leading to stroke, heart failure and final stage cardiovascular disorders will keep the VENTRICULAR ASSIST DEVICESs in demand on a global level. Increased focus of large players on emerging markets will further bring in new opportunities for VENTRICULAR ASSIST DEVICESs market.

Regional Outlook and Trend Analysis: North America has the biggest regional contribution to the search segment in the Ventricular Assist Devices market; APEJ is anticipated to develop at a quicker rate and almost be equal to North America over the upcoming years. North America: (U.S., Canada & Mexico), Europe: (Germany, UK, France, Russia, Italy & Rest of Europe), Asia-Pacific: (China, Japan, South Korea, India, Southeast Asia & Rest of Asia-Pacific), South America: (Brazil, Argentina, Columbia, South Africa & Rest of South America) and Middle East and Africa: (Saudi Arabia, UAE, Egypt, Nigeria, South Africa & Rest of MEA)

Browse Complete Report with TOC: https://www.crystalmarketresearch.com/report/ventricular-assist-devices-market .

Table of Contents:
Part 1. Introduction

Part 2. Executive Summary

Part 3. Market Overview

Part 4. Ventricular Assist Devices Market, By Product
4.1. Introduction
4.3. Left Ventricular Assist Devices (LVADs)
4.4. Right Ventricular Assist Devices (RVADs)
4.5. Biventricular Assist Devices (BIVADs)

Part 5. Ventricular Assist Devices Market, By Application
5.1. Introduction
5.2. Ventricular Assist Devices Market Assessment and Forecast, By Application, 2016-2025
5.3. BTT and BTD Therapies
5.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.4. Destination Therapy

Part 6. Ventricular Assist Devices Market, By Design
6.1. Introduction
6.2. Ventricular Assist Devices Market Assessment and Forecast, By Design, 2016-2025
6.3. Percutaneous VADs
6.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
6.4. Destination Therapy
6.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
...…...

Part 8. Company Profiles
9.1. Abiomed, Inc.
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Key Financials
9.1.4. Strategic Developments

9.2. Boston Scientific Corporation
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Key Financials
9.2.4. Strategic Developments

9.3. Berlin Heart GmbH
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Key Financials
9.3.4. Strategic Developments

9.4. Biotronik SE & Co. KG
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments

9.5. LivaNova PLC
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Key Financials
9.5.4. Strategic Developments
…

In 2016, North America dominated the global VENTRICULAR ASSIST DEVICESs market with highest market share. This dominance can be attributed to the presence of huge patient population along with high adoption of technologically advanced products and high disposable income of the population. With the presence of sophisticated healthcare infrastructure the market will show significant growth over the forecast period.

Market Updates:
Boston Scientific Corporation Presents at BMO Prescriptions for Success Healthcare Conference, Dec-12-2018 11:20 AM. Venue: Mandarin Oriental Hotel, 80 Columbus Circle, New York, New York, United States. Speakers: Susan Vissers Lisa, Vice President of Investor Relations.

BIOTRONIK announced two-year data from the BIOFLOW-V randomized trial comparing the Orsiroa and Xienceb drug-eluting stents (DES). The data shows statistically improved outcomes for patients treated with Orsiro across a range of clinical endpoints including 24-month target lesion failure (TLF). This pivotal US investigational device exemption trial included a large, complex patient population (n=1,334) and was designed to rigorous FDA premarket approval standards. Also Biotronik has announced the launch of its Evity cardiac resynchronization therapy pacemaker (CRT-P) in the Japanese market. It is the company's highest performing CRT-P with a battery life of almost 10 years. Quadripolar technology allows for increased options in pacing the left ventricle (LV).

Asia-Pacific will exhibit fastest growth during the forecast period due to rising number of cases related to diabetic disorders. Promotion of medical tourism activities by governments in various emerging economies to offer cost effective treatment to foreign patients is set to boost the market growth of VENTRICULAR ASSIST DEVICESs.

Reason to Buy:
Focus key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Ventricular Assist Devices market, thereby allowing players to develop effective long term strategies. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Additionally, key Ventricular Assist Devices market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 5 years, key development in past five years.

(Early Buyer will receive 10% customization in this report.)

Make Preorder Enquiry: https://www.crystalmarketresearch.com/send-an-enquiry/HC0624 .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contacts Us
Judy | 304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
E-mail: sales@crystalmarketresearch.com | Ph: +1-888-213-4282

This release was published on openPR.